Home
Overview
Project
Consortium
News
Contact
NEWS
Home
News
New graphics explain the science behind CLINGLIO
(25/01/2021)
Read More
The European Commission has granted a 12-month extension to the CLINGLIO project
(11/08/2021)
Read More
Conclusions of the Ib safety trial were presented in ESMO 2021
(24/09/2021)
Read More
Glioblastoma Awareneness sessions
(11/07/2022)
Read More
New article published on Cancer Journal: The Novel Antitumor Compound HCA Promotes Glioma Cell Death by Inducing Endoplasmic Reticulum Stress and Autophagy
(26/08/2021)
Read More
New article published; Hydroxylated Fatty Acids: The Role of the Sphingomyelin Synthase and the Origin of Selectivity
(11/10/2021)
Read More
New article: Development of the Membrane Lipid Therapy
(24/11/2021)
Read More
Luz verde a CLINGLIO para invertir 6,15 millones de la UE en el siguiente ensayo clínico del Minerval
(28/01/2018)
Read More
New article published; Fundamentals of Membrane Lipid Replacement
(29/11/2021)
Read More
6.15 M€ Grant by the H2020 Programme to Conduct a PIIb Trial with 2OHOA in Patients with newly-diagnosed Glioblastoma
(21/01/2018)
Read More
Article published; Tri-2-Hydroxyarachidonein Impairs Cell Proliferation and Viability of Human Pancreatic Carcinoma and Human Pancreatic Carcinoma of Ductal Cell Lines
(20/01/2022)
Read More
New sctientific article about Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation
(07/02/2022)
Read More
17 leading hospitals and research centres form across Europe work on CLINGLIO
(20/01/2021)
Read More
New Protocol was submitted
(15/03/2022)
Read More
First batch of medication was released in the new sachet formulation
(01/11/2020)
Read More
Follow the CLINGLIO project updates and glioblastoma news on our Twitter account
(21/08/2021)
Read More
New site opened in Madrid, Spain
(13/05/2022)
Read More
First shipment of sachets is a new important milestone for the project and will reduce carbon footprint
(30/04/2022)
Read More
CLINGLIO KICKOFF MEETING
(18/02/2018)
Read More
